Capital Group Growth ETF Struggles Despite Strong Holdings
The Capital Group Growth ETF (CGGR) has positioned itself as a contender in the active growth fund space, focusing on major players like Meta, Tesla, Nvidia, and Broadcom. Despite impressive revenue growth from these companies—Nvidia reported an 85% increase in revenue year-over-year, while Meta saw a 33% rise—CGGR's overall performance has been disappointing. Over the past year, the fund returned approximately 11%, significantly trailing the S&P 500's 21% and the Nasdaq-100's 25% returns. This raises questions about the effectiveness of its active management strategy, especially given its expense ratio of 0.39%, which is lower than many actively managed funds but still higher than leading passive growth ETFs.
The fund's strategy is built on the premise that a concentrated portfolio of megacap stocks can outperform the market. However, the results have not aligned with this expectation. Investors who opted for CGGR for its focus on the so-called Magnificent Seven have found themselves underwhelmed, as the fund's returns have lagged behind those of several passive alternatives. Year-to-date, CGGR has gained less than 4%, while the S&P 500 and Nasdaq-100 have seen gains of around 10% and 15%, respectively.
Looking at a longer timeframe, CGGR has performed better since early 2022, with returns of roughly 90%, comparable to Vanguard's VUG and Schwab's SCHG. However, this performance still falls short of the Nasdaq-100's impressive 97% return. The challenge for active management in a market dominated by a few large-cap stocks is significant. Any underweighting of these stocks can lead to substantial underperformance, particularly when they are the year's best performers.
The fund's low turnover rate of around 16% suggests a reluctance to make aggressive bets outside its core holdings, which could limit its ability to capitalize on market shifts. If the megacap trade falters, CGGR may struggle to keep pace, as evidenced by Nvidia's high valuation and significant influence on the fund's performance. While CGGR remains a credible option for growth investors, its recent underperformance raises concerns about its viability as a standalone investment for those seeking exposure to top-performing stocks.
Investors considering CGGR must evaluate whether they believe in the fund's long-term strategy and the value of its active management approach. For those primarily interested in exposure to the Magnificent Seven, passive alternatives may offer better performance at a lower cost. CGGR could be more suitable as a satellite investment for those who value Capital Group's research process, rather than as a primary vehicle for growth exposure.
